- In Connecticut, Doctors Now Sue Patients Most Over Medical Bills, Surpassing Hospitals
- An Arm and a Leg: The Accidental Architect of America’s Drug Patent Problem
- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
The Centers for Medicare & Medicaid Services' (CMS) Office of the Actuary publishes a summary of healthcare expenditures about one year after the fact. Useful to assess the roles of various players in health care. Here is their most recent health care expenditures report, on calendar year 2022:
https://www.cms.gov/newsroom/fact-sheets/national-health-expenditures-2022-highlights
National Health Expenditures 2022 Highlights
Dec 13, 2023
U.S. health care spending grew 4.1% to reach $4.5 trillion in 2022, faster than the increase of 3.2% in 2021, but much slower than the rate of 10.6% in 2020. The growth in 2022 reflected strong growth in Medicaid and private health insurance spending that was somewhat offset by continued declines in supplemental funding by the federal government associated with the COVID-19 pandemic.
In 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. In 2022, 26.6 million individuals were uninsured, down from 28.5 million in 2021 (a difference of 1.9 million individuals).
Gross domestic product (GDP) continued to increase at strong rates of growth in both 2021 and 2022, increasing 10.7% and 9.1%, respectively. With a lower rate of health care spending growth of 4.1% in 2022, the share of GDP devoted to health care fell to 17.3% in 2022, lower than both the 18.2% share in 2021 and the highest share in the history of the National Health Expenditure Accounts of 19.5% in 2020. During 2016-19 the average share was 17.5%.
Federal COVID-19 supplemental funding to the health sector through the Provider Relief Fund and the Paycheck Protection Program was highest during the initial year of the pandemic and continued to affect health care expenditures in 2021 and 2022, although at reduced levels. Funding to the health sector through these programs was $174.6 billion in 2020, but just $2.0 billion in 2022.
Health Spending by Type of Service or Product:
- Hospital Care (30% share): Spending for hospital care services increased 2.2% in 2022 to reach $1.4 trillion; however, this was a slower growth rate compared to 4.5% that was experienced in 2021. The slower growth in 2022 reflected a slowdown in spending for hospital care by private health insurance, Medicare, and Medicaid and by a decline in other private revenues. Slower growth in hospital prices and a decline in hospital days and discharges contributed to the lower growth in 2022.
- Physician and Clinical Services (20% share): billion in 2022, slower than the increase of 5.3% in 2021. Spending growth for physician and clinical services slowed in 2022 for the major payers — Medicare, Medicaid, private health insurance, and out-of-pocket. Slower growth in the use of services and in physician prices contributed to the slower growth in 2022.
- Retail Prescription Drugs (9% share): Retail prescription drug spending increased 8.4% to $405.9 billion in 2022, a faster rate than in 2021 when spending increased by 6.8%. Medicare and out-of-pocket spending growth for retail prescription drugs accelerated, while Medicaid and private health insurance spending growth slowed. The faster growth in 2022 was influenced by faster growth in the number of prescriptions dispensed and an increase in retail prescription drug prices (1.2% in 2022) after four consecutive years of decline.
- Other Health, Residential, and Personal Care Services (6% share): This category includes expenditures for medical services that are generally delivered by providers in non-traditional settings, such as schools, community centers, and the workplace, as well as by ambulance providers and residential mental health and substance abuse facilities. Spending for other health, residential, and personal care services grew 9.7% in 2022 to $246.5 billion, accelerating from 6.7% growth in 2021. The faster growth in 2022 was driven primarily by an acceleration in spending for Medicaid home and community-based waivers.
- Nursing Care Facilities and Continuing Care Retirement Communities (4% share): Spending for services provided at freestanding nursing care facilities and continuing care retirement communities rose in 2022 by 5.6% to $191.3 billion, compared to a decline of 7.8% in 2021. Medicaid, out-of-pocket, and Medicare account for over three quarters of total payments to these facilities and, in 2022, spending for these payers had strong growth following low growth or reduced spending in 2021.
- Dental Services (4% share): Spending for dental services increased just 0.3% in 2022 to $165.3 billion following much faster growth of 18.2% in 2021. The slowdown was driven by slower growth for all the major payers, but particularly for out-of-pocket and private health insurance, as well as a decline in federal funding from Paycheck Protection Program loans and the Provider Relief Fund.
- Home Health Care (3% share): Spending for services provided by freestanding home health care agencies increased 6.0% in 2022 to $132.9 billion, accelerating from growth of 0.3% in 2021. Private health insurance, out-of-pocket, and Medicaid home health spending contributed to the faster growth, while Medicare spending growth for home health care services slowed.
- Other Professional Services (3% share): Spending for other professional services includes establishments of independent health practitioners (except physicians and dentists) that primarily provide services, such as physical therapy, optometry, podiatry, or chiropractic medicine. Spending for other professional services reached $140.6 billion in 2022 and increased 5.1%, a slower rate of growth compared to 13.2% in 2021. The slowdown was driven by slower growth in Medicare, private health insurance, and out-of-pocket spending, coupled with reduced supplemental COVID-relief funding.
- Other Non-durable Medical Products (3% share): Retail spending for other non-durable medical products, such as over-the-counter medicines, medical instruments, and surgical dressings, increased 8.5% to $115.4 billion in 2022, slower than in 2021 when spending increased 12.3%. Out-of-pocket spending accounted for 98% of total spending for other non-durable medical products in 2022.
- Durable Medical Equipment (2% share): Retail spending for durable medical equipment, which includes items such as contact lenses, eyeglasses, and hearing aids, increased 5.1% in 2022 to $67.1 billion, following much faster growth of 18.6% in 2021. The slowdown in 2022 was driven by slower growth in out-of-pocket and private health insurance spending.
Health Spending by Major Sources of Funds:
- Private Health Insurance (29% share): Private health insurance spending increased by 5.9% in 2022 (to $1.3 trillion), which was slightly slower than the increase of 6.3% in 2021. For hospital care, physician and clinical services, and dental services, private health insurance expenditures grew more slowly in 2022, following stronger growth in 2021. Private health insurance enrollment increased 1.5%, or 2.9 million individuals, in 2022 — the fastest increase since 2015.
- Medicare (21% share): Medicare spending increased 5.9% to reach $944.3 billion in 2022, a slower increase than in 2022 when Medicare spending increased 7.2%. Medicare fee-for-service expenditures declined by 1.9% in 2022, while Medicare private health plan spending (accounting for 50% of total Medicare spending) increased 15.1%. Total Medicare enrollment increased 1.9% in 2022 compared to growth of 1.7% in 2021 (or by 1.2 million individuals), with enrollment in Medicare private plans increasing 8.5% and fee-for-service enrollment declining 3.0%.
- Medicaid (18% share): Medicaid spending increased 9.6% to $805.7 billion in 2022, the third consecutive year of growth above 9%. Medicaid enrollment grew 7.2% in 2022 after increasing 11.1% in 2021 and 4.6% in 2020. This amounts to about 18 million individuals gaining Medicaid coverage between 2019 and 2022. Faster Medicaid enrollment growth since 2019 reflects the newly enrolled as well as the continuous enrollment requirement of the Families First Coronavirus Response Act that took effect on March 18, 2020 and ended on March 31, 2023. Federal Medicaid spending increased 10.8% and state Medicaid spending increased 6.6% in 2022, with the federal government’s share of total Medicaid spending reaching 71% in 2022.
- Out-of-Pocket (11% share): Total out-of-pocket spending increased by 6.6% in 2022 to $471.4 billion, slowing from growth of 11.0% in 2021. Dental services, durable medical equipment, and physician and clinical services, which collectively accounted for 34% of all out-of-pocket spending in 2022, were the main contributors to the slower growth in 2022.
Health Spending by Type of Sponsor[1]:
- In 2022, the federal government and households accounted for the largest shares of national health spending (33% and 28%, respectively), followed by private businesses (18%), state and local governments (15%), and other private revenues (6%).
- Federal government spending for health care increased 1.0% in 2022 following a 3.4% decline in 2021. The federal portion of Medicaid payments increased 10.8% in 2022 compared to 11.6% in 2021. The continued strong growth in federal Medicaid expenditures can be attributed to rapid enrollment growth and to the Families First Coronavirus Response Act’s temporary 6.2 percentage-point increase in the federal medical assistance percentage. Conversely, spending for other federal health insurance programs continued to decline in 2022 due to reduced COVID-19 federal funding.
- Health care spending by households grew 6.9% in 2022, similar to the rate of 6.8% in 2021. Faster growth in premiums and payroll taxes that were paid for Medicare, as well as faster growth in household contributions to employer-sponsored private health insurance premiums, offset slower growth in out-of-pocket spending on health care.
- State and local government health care expenditures increased 6.5% in 2022, following a similar growth rate of 6.2% in 2021. Faster growth in state Medicaid spending (a 35% share of state and local spending) more than offset slower growth in state and local government contributions to employer-sponsored private health insurance premiums (29% share of state and local spending).
- Spending on health care by private businesses increased 6.0% in 2022, a slower rate than the increase of 7.6% in 2021. The largest share of private businesses’ health spending was contributions to employer-sponsored private health insurance premiums (a 75% share), which increased at a slower rate in 2022 (5.9 %) compared to growth of 7.2% in 2021.
[1] Type of sponsor is defined as the entity that is ultimately responsible for financing the health care bill, such as private businesses, households, and governments. These sponsors pay health insurance premiums and out-of-pocket costs, or finance health care through dedicated taxes and/or general revenues.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














